|
NKTR | Nektar Therapeutics |
|
|
NKTR | Nektar Therapeutics |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.26 |
| Leverage | 84.13% |
| Market Cap | $ 189.1m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -167.0m |
| Margin | -231.70% |
Nektar Therapeutics is a biopharmaceutical company. The company is headquartered in San Francisco, California with additional operations in Huntsville, Alabama and Hyderabad, India.